Satigem's main ingredient is Gemcitabine, prepared in the form of lyophilized powder for intravenous infusion. Satigem is used in the treatment of certain cancers.

The group of non-small cell lung cancers accounts for about 85% of lung cancers. This article introduces a recently used chemotherapy to treat this group of lung cancers at multiple stages: Locally advanced, regionally or metastatic.